Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

German expats in China receive first foreign COVID vaccines

Published 05/01/2023, 08:05
Updated 05/01/2023, 12:27
© Reuters. FILE PHOTO: A test tube labelled "COVID-19 Test Positive" and a vial labelled "VACCINE Coronavirus COVID-19" are seen in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration

BEIJING (Reuters) - Germans living in China began receiving the BioNTech COVID-19 vaccine on Thursday, the first such rollout of a foreign coronavirus vaccine in a country that has not otherwise approved the use of non-Chinese vaccines even as infections soar.

Under an agreement reached during a visit to Beijing by Chancellor Olaf Scholz in November, Germans aged 12 and older may receive their first dose or a booster of the BioNTech vaccine at a designated international hospital in Beijing, Shanghai, Shenyang, Guangzhou or Chengdu.

Marcus Wellendorf, 59, a documentary film maker, said he had received three doses of Chinese vaccines.

"Especially in the current situation, after China opened up very suddenly, I feel that an additional BioNTech booster is very comforting to have," he told Reuters at Beijing United Family Hospital, where 25 people had made bookings to be vaccinated.

More than 8,000 doses of the BioNTech vaccine, which was developed with Pfizer (NYSE:PFE) and is being distributed under COMIRNATY branding, have been shipped to China and more than 1,500 people have registered their interest, Germany's foreign ministry said on Tuesday.

About 14,000 German nationals live in China, according to the embassy.

German officials are "trying to expand the offer to other nationalities as well," its foreign ministry said.

China has so far insisted on using only domestically produced vaccines, shunning Western-made vaccines that use newer mRNA technology.

China, home to 1.4 billion people, abruptly abandoned its "zero-COVID" policy last month and infections are surging across a population with little immunity after being shielded since the virus emerged three years ago in the Chinese city of Wuhan.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On Tuesday, the European Union offered free COVID-19 vaccines to China. Asked whether Beijing would accept the offer, Chinese Foreign Ministry spokesperson Mao Ning said China's vaccine supplies were adequate.

The arrangement allowing Germans in China to receive the BioNTech vaccine is reciprocal, and Chinese nationals living in Germany can also be vaccinated with China's SinoVac, a German government spokesperson said last month.

SinoVac did not immediately respond to an email query seeking comment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.